STAT+: Aurobindo, major generic drug maker, will close a key U.S. production plant
Aurobindo Pharma, which is based in India and is one of the largest global producers of generic medicines, is closing its U.S. manufacturing facility in New Jersey next month, according to a notice filed with the state Department of Labor.
drug., and will eliminate a total of 99 jobs as of April 26. No further details were provided and calls to the facility were not returned. No one at Aurobindo headquarters in Hyderabad, India, could be reached for comment.
Continue to STAT+ to read the full story…
